ShadowBuys
Sign inJoin for free
Committee overlap: Energy and CommerceTraded 13 days before earnings

Rep. Thomas H. Kean, Jr. sold Johnson & Johnson (JNJ)

Rep. Thomas H. Kean, Jr. (R-NJ-7) · $1K–$15K · traded Sep 30, 2026

Why this is a committee overlap

Kean is a member of the House Committee on Energy and Commerce, which oversees the Healthcare sector. Johnson & Johnson is classified in the Drug Manufacturers - General industry.

An overlap is a fact about the trade, not evidence of wrongdoing. Committee assignments are current ones.

Traded before earnings

Johnson & Johnson reported its results on Oct 13, 2026, 13 days after this trade. See the SEC filing ↗

Companies usually announce these dates ahead of time. Trading before one isn’t evidence the member knew the results.

Transaction
Sold (partial)
Amount
$1K–$15K
Owner
Not stated
Traded
Sep 30, 2026
Disclosed
Oct 30, 2026
Days to disclose
30
Asset type
Stock
As filed
Johnson & Johnson Common Stock
Industry
Drug Manufacturers - General · Healthcare
Official filing ↗All of Kean's tradesAll Congress trades in JNJ

Other trades in this filing

Recent Congress trades in JNJ

Company context for JNJ

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. JNJFinancial report·SEC EDGAR

    JNJ: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-27. Read the company report for its disclosures.

    Public: Oct 21, 2026, 4:18 PM EDTEvent / period: Sep 27, 2026Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  2. JNJLobbying report·Lobbying disclosures

    JNJ: third_quarter 2026 lobbying report

    Issues related to the 340B Drug Pricing Program. Issues related to the 340B Drug Pricing Program.

    Public: Oct 20, 2026, 12:00 AM EDTOriginal source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  3. JNJLobbying report·Lobbying disclosures

    JNJ: third_quarter 2026 lobbying report

    HR 6549, VA Contracting and Procurement Act PBM Medical Supply Chain program reforms, MSPV, PSAS, IT HR 9237, Taking Care of Veterans Act S2918, Veterans Prosthetics Advancement and Reform Act

    Public: Oct 16, 2026, 12:14 PM EDTOriginal source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.